Rize Oncology Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2	3	2	5	-	-
Market Cap Growth	-	125.00%	-67.83%	-	-	-
Enterprise Value	1	2	-0	2	-	-
Last Close Price	0.03	0.09	0.04	0.10	-	-
PB Ratio	1.42	2.19	0.86	1.92	-	-
P/TBV Ratio	1.42	2.19	0.86	1.92	-	-
Debt / Equity Ratio	-	-	-	-	-	-1.57
Quick Ratio	13.98	13.98	35.33	20.54	0.84	0.37
Current Ratio	14.35	14.35	36.56	22.24	1.74	0.37
Return on Equity (ROE)	-44.40%	-44.40%	-42.64%	-170.34%	-4122.37%	-
Return on Assets (ROA)	-28.28%	-28.28%	-27.84%	-92.74%	-492.06%	-153.75%
Return on Invested Capital (ROIC)	-29.67%	-29.67%	-28.93%	-106.58%	-1015.04%	-159.59%
Earnings Yield	-34.88%	-22.73%	-58.66%	-48.18%	-	-
Buyback Yield / Dilution	16.52%	16.52%	-7.75%	-20.45%	-32.93%	-3729.11%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.